The Pittsburgh (PA) Post-Gazette (2/9, Smydo) reports, “The University of Pittsburgh Graduate School of Public Health will participate in a study that could hasten the day when a patient’s genetic profile, not trial and error, helps a doctor determine which medications to prescribe.” Included in the “28-month, $350,000 study” will be “about 400 volunteers with mental-health disorders who are clients of NHS Human Services in Allegheny, Beaver, Dauphin and Lehigh counties.” Investigators “will analyze genetic material from about half of the volunteers and use those insights to make medication adjustments aimed at optimizing drug performance and decreasing side effects and adverse drug interactions,” while the other participants, who will serve as the control group, will get “usual care.”
Related Links:
— “Pitt study seeks to refine prescribing through genetics,” Joe Smydo, Pittsburgh Post-Gazette, February 9, 2015.